Cargando…

Local staging of prostate cancer with imaging: can hybrid imaging be the solution?

Detalles Bibliográficos
Autor principal:	Turkbey, Baris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214973/ https://www.ncbi.nlm.nih.gov/pubmed/32420194 http://dx.doi.org/10.21037/tau.2020.03.12

Ejemplares similares

Multiparametric MRI in Prostate Cancer
por: Esen, Tarık, et al.
Publicado: (2014)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
por: An, Julie Y., et al.
Publicado: (2017)

Hybrid imaging is the future of molecular imaging
por: Hicks, RJ, et al.
Publicado: (2007)

Can we produce an image of bacteria with radiopharmaceuticals?
por: Signore, A., et al.
Publicado: (2008)

Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?
por: Jadvar, Hossein
Publicado: (2012)

Implications of local failure on overall prognosis in aggressive prostate cancer
por: Mula-Hussain, Layth, et al.
Publicado: (2020)

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple “MIRAGE”?
por: Bosetti, Davide Giovanni, et al.
Publicado: (2023)

Positron emission tomography (PET) in primary prostate cancer staging and risk assessment
por: Bednarova, Sandra, et al.
Publicado: (2017)

Magnetic resonance microscopy of prostate tissue: How basic science can inform clinical imaging development
por: Bourne, Roger
Publicado: (2013)

Quick guide on radiology image pre-processing for deep learning applications in prostate cancer research
por: Masoudi, Samira, et al.
Publicado: (2021)

Local therapy in patients with metastatic prostate cancer: a new standard of care?
por: Harper, Benjamin, et al.
Publicado: (2019)

Consensus on the Screening, Staging, Treatment, and Surveillance of Localized, Recurrent, and Metastatic Prostate Cancer: The First Global Prostate Cancer Consensus Conference for Developing Countries
por: Maluf, Fernando Cotait, et al.
Publicado: (2021)

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer
por: Czarniecki, Marcin, et al.
Publicado: (2018)

The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging
por: D’Onofrio, Mirko, et al.
Publicado: (2017)

Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
por: Bax, Jeroen J., et al.
Publicado: (2008)

High-Resolution Diffusion-weighted Imaging Increases Prostate Cancer Visibility?
por: Fütterer, Jurgen J.
Publicado: (2016)

Tasks for artificial intelligence in prostate MRI
por: Belue, Mason J., et al.
Publicado: (2022)

Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment options
por: Chaurasia, Avinash R, et al.
Publicado: (2020)

Diagnosing Subtypes of Progressive Supranuclear Palsy: Can (18)F-FDG PET/CT Imaging Guide Our Way?
por: Desai, Ishita, et al.
Publicado: (2022)

Can magnetic resonance imaging differentiate undifferentiated arthritis?
por: Østergaard, Mikkel, et al.
Publicado: (2005)

Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?
por: Chau, Brittney, et al.
Publicado: (2019)

Atrial fibrillation ablation in end-stage renal Disease:...Yes, we can!
por: Kowlgi, Gurukripa N., et al.
Publicado: (2021)

Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer
por: Vlaeminck-Guillem, Virginie
Publicado: (2020)

Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
por: Valentin, B., et al.
Publicado: (2021)

Multimodal Imaging and Hybrid Scanners
por: Azhari, Haim, et al.
Publicado: (2007)

Theranostic Hybrid Molecular Imaging
por: Gambini, Juan Pablo
Publicado: (2014)

The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Unconstrained image reconstruction with resolution modelling does not have a unique solution
por: Nuyts, Johan
Publicado: (2014)

Can biopsy be avoided in patients with clinical suspicion of prostate cancer and a negative result on multiparametric magnetic resonance imaging?
por: Baroni, Ronaldo Hueb
Publicado: (2019)

Tracked Foley catheter for motion compensation during fusion image-guided prostate procedures: a phantom study
por: Hale, Graham R., et al.
Publicado: (2020)

Current Status of Biparametric MRI in Prostate Cancer Diagnosis: Literature Analysis
por: Belue, Mason James, et al.
Publicado: (2022)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008)

Choroidal imaging: Looking ahead
por: Chhablani, Jay, et al.
Publicado: (2015)

PSMA-targeted imaging of prostate cancer: evolution of a success story
por: Maurer, Tobias, et al.
Publicado: (2017)

Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
por: Mayer, Rulon, et al.
Publicado: (2023)

Importance of measurement repeatability of semi-quantitative imaging through PET-CT and PET-MR imaging in oncology
por: Priola, Adriano Massimiliano, et al.
Publicado: (2019)

A British Society of Thoracic Imaging statement: considerations in designing local imaging diagnostic algorithms for the COVID-19 pandemic
por: Nair, A., et al.
Publicado: (2020)

The multiparametric prostate resonance imaging with the prostate imaging-reporting and data system (PI-RADS): the state of art of prostate cancer diagnosis
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vf6ochlrvjtt1mpgrvkcq48kqr